Sequoia Financial Advisors LLC Makes New $273,000 Investment in Bath & Body Works, Inc. $BBWI

Sequoia Financial Advisors LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 9,096 shares of the company’s stock, valued at approximately $273,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in BBWI. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Bath & Body Works by 38.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company’s stock worth $1,265,000 after buying an additional 11,681 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Bath & Body Works by 15.5% during the first quarter. Blue Trust Inc. now owns 4,184 shares of the company’s stock worth $127,000 after buying an additional 560 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of Bath & Body Works by 3.6% during the first quarter. Oppenheimer Asset Management Inc. now owns 54,249 shares of the company’s stock worth $1,645,000 after buying an additional 1,894 shares in the last quarter. Lecap Asset Management Ltd. grew its holdings in shares of Bath & Body Works by 43.5% during the first quarter. Lecap Asset Management Ltd. now owns 106,629 shares of the company’s stock worth $3,233,000 after buying an additional 32,345 shares in the last quarter. Finally, Bessemer Group Inc. grew its holdings in shares of Bath & Body Works by 26.9% during the first quarter. Bessemer Group Inc. now owns 22,769 shares of the company’s stock worth $691,000 after buying an additional 4,827 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Down 1.1%

Shares of BBWI stock opened at $26.08 on Thursday. The stock has a market cap of $5.38 billion, a price-to-earnings ratio of 7.74, a price-to-earnings-growth ratio of 0.91 and a beta of 1.52. Bath & Body Works, Inc. has a fifty-two week low of $24.85 and a fifty-two week high of $41.87. The firm’s 50 day moving average price is $27.58 and its two-hundred day moving average price is $29.06.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the company posted $0.37 earnings per share. Bath & Body Works’s revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s payout ratio is presently 23.74%.

Wall Street Analyst Weigh In

BBWI has been the subject of a number of recent research reports. Barclays lowered their price target on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a report on Monday. UBS Group lowered their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a report on Friday, August 29th. Jefferies Financial Group lowered their target price on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a report on Monday, October 13th. Telsey Advisory Group restated an “outperform” rating and issued a $38.00 target price on shares of Bath & Body Works in a report on Thursday, August 28th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $37.18.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.